Understand the history of prostate carcinoma diagnosis including clinical documentation, medical coding (ICD-10 C61), staging (TNM), Gleason score, and PSA levels. Find information on risk factors, screening, diagnostic procedures like biopsy, and treatment options for prostate cancer. This resource offers guidance for healthcare professionals on accurate and complete documentation for optimal patient care and reimbursement.
Also known as
Personal history of malignant neoplasm of prostate
History of prostate cancer.
Malignant neoplasm of prostate
Current prostate cancer, which may be relevant to history.
Factors influencing health status and contact with health services
Includes personal history of malignant neoplasms (Z85).
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the prostate cancer currently active?
Yes
Is there metastasis?
No
Status post treatment?
When to use each related code
Description |
---|
History of Prostate Cancer |
History of Benign Prostatic Hyperplasia |
History of Prostatitis |
Coding prostate cancer without specifying laterality (right, left, or bilateral) leads to inaccurate reporting and potential claim issues.
Miscoding active prostate cancer as history of prostate cancer, or vice versa, impacts treatment authorization and quality metrics.
Failure to document treatment status (e.g., treated, in remission) creates coding ambiguities and affects reimbursement accuracy.
Patient presents with a history of prostate carcinoma. Initial diagnosis of prostate cancer was established on [Date of original diagnosis] based on [Diagnostic method, e.g., biopsy findings showing adenocarcinoma, Gleason score X]. The patient's original prostate cancer treatment included [Treatment details, e.g., radical prostatectomy, radiation therapy, brachytherapy, androgen deprivation therapy]. Current presentation includes [Reason for visit, e.g., routine follow-up, rising PSA, new onset bone pain]. Physical exam reveals [Relevant findings, e.g., normal rectal exam, palpable lymph nodes]. Prostate-specific antigen (PSA) level is currently [PSA value with units and date]. Imaging studies including [Imaging modality and date, e.g., bone scan, CT scan, MRI] show [Imaging findings, e.g., no evidence of recurrent disease, suspicious lesion in bone]. Assessment: History of prostate cancer, now [Status, e.g., in remission, with biochemical recurrence, metastatic]. Plan includes [Plan of care, e.g., continued surveillance with PSA testing, imaging studies, referral to medical oncology, initiation of hormonal therapy]. Differential diagnoses at initial presentation included benign prostatic hyperplasia (BPH) and prostatitis. Coding considerations include ICD-10 code Z85.820 (Personal history of malignant neoplasm of prostate) and relevant codes for current symptoms, treatment, and surveillance. Medical billing should reflect evaluation and management (E M) services as well as any procedures performed.